Vaccine doubles survival of deadly brain cancer
CHICAGO (Reuters) - A cancer vaccine more than doubled the survival time of people with the most common and deadly type of brain tumor, U.S. researchers said on Monday.
<p><img src="http://feeds.feedburner.com/~a/reuters/healthNews?i=0NRhl8" border="0"></img> (http://feeds.feedburner.com/~a/reuters/healthNews?a=0NRhl8)</p><div class="feedflare">
<img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=M68j7I" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=M68j7I) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=tHKXii" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=tHKXii) <img src="http://feeds.feedburner.com/~f/reuters/healthNews?i=afLLfi" border="0"></img> (http://feeds.feedburner.com/~f/reuters/healthNews?a=afLLfi)
</div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/303050986" height="1" width="1"/>
http://feeds.feedburner.com/~r/reuters/healthNews/~3/303050986/idUSN0232490720080602